Why This Matters Now

The CMS 2026 Physician Fee Schedule Final Rule offers another signal that the U.S. healthcare system continues to accelerate its shift toward value based and risk-based care.

For health technology companies looking to expand their footprint in the United States, this policy movement matters more than it may appear at first glance.

The rule moves Medicare further toward performance-based reimbursement, clinician level accountability and integrated care delivery. Providers that demonstrate improved outcomes and more efficient care delivery are increasingly rewarded within the reimbursement framework.

Several policy signals are clear.

Greater emphasis is being placed on value and risk sharing rather than traditional fee for service billing.

Providers participating in alternative payment models are seeing stronger incentives tied to performance and cost management.

At the same time, CMS continues to expand its focus on chronic care management, prevention and care coordination within the Medicare Physician Fee Schedule, which governs payment for services delivered by physicians and other clinicians.

These adjustments reinforce a broader policy direction. Medicare reimbursement is increasingly structured around measurable outcomes and population level performance.

System Level Analysis

During the better part of a decade that I worked at CMS I came to realize that the Physician Fee Schedule is one of the most influential policy levers within the U.S. healthcare system.

Each annual rule does more than adjust reimbursement levels. It signals how CMS expects care delivery to evolve across the provider ecosystem.

The 2026 rule continues a multi year transition toward integrated care delivery models where providers are accountable for quality, cost and patient outcomes.

In this environment, physicians and health systems must increasingly manage populations rather than isolated clinical encounters. Performance measurement, care coordination and cost management become central operational capabilities rather than peripheral activities.

Reimbursement design therefore begins to shape technology adoption.

When payment rewards outcome improvement and cost control, providers look for infrastructure that enables those results at scale.

Second Order Effects Across the Ecosystem

Policy changes in Medicare reimbursement rarely affect only providers. They cascade across the broader healthcare ecosystem.

• As reimbursement shifts toward risk based arrangements, provider organisations require tools that support population health management, real time patient monitoring and continuous care coordination.
• Digital infrastructure becomes essential for tracking outcomes, identifying risk earlier and managing patients outside traditional care settings.
• Technology adoption increasingly follows reimbursement incentives.
• When providers operate under value-based contracts, they require systems capable of measuring performance across programmes, coordinating multidisciplinary care teams and reducing avoidable hospitalisations.

The commercial case for digital health infrastructure therefore strengthens as reimbursement reform accelerates.

Implications for EU Healthtech Companies

For European healthtech companies evaluating U.S. expansion, the Physician Fee Schedule is not simply a regulatory update.

It is a signal about how provider demand will evolve.

• Providers operating within value-based contracts increasingly need technology that enables population health management, outcome measurement and continuous patient engagement.
• Solutions focused on chronic disease management, remote monitoring, data analytics and care coordination align directly with the operational challenges created by these payment models.

For EU innovators, the strategic question is not whether value-based care will expand.

It is how well their products help providers succeed within risk bearing environments.

Companies that design their solutions around measurable performance improvement will be better positioned as Medicare reimbursement continues to evolve.

Handrails for Leaders

• Map your solution against value-based care requirements within Medicare programmes.
• Demonstrate measurable impact on cost, outcomes and patient engagement.
• Design products that support population health management and longitudinal care.
• Prepare evidence showing how technology enables providers to succeed within risk bearing contracts.
• Engage early with provider organisations participating in alternative payment models.

Closing Thought

The 2026 Physician Fee Schedule reinforces a consistent policy trajectory within U.S. healthcare.

Reimbursement is gradually shifting toward models that reward outcomes, coordination and long-term population health performance.

As that transition continues, technology capable of helping providers manage risk, measure results and deliver more integrated care will move from optional infrastructure to operational necessity.

For healthtech innovators, the opportunity lies in helping providers succeed in that environment.

Author

Thomas Hennessy is Senior Advisor at Santegic, supporting companies with U.S. market entry, regulatory strategy, and commercial growth in health technology and MedTech.Reach out to Tom directly or learn more at www.santegic.com.